%PDF-1.4
%
25 0 obj
<>
endobj
22 0 obj
<>
endobj
80 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-04-09T16:58:31Z
2024-03-29T07:45:21-07:00
QuarkXPressª 4.11: AdobePS 8.6 (219)
2024-03-29T07:45:21-07:00
application/pdf
Heather
2003-110.may
uuid:3ec08b11-1dd2-11b2-0a00-640827bd7200
uuid:3ec08b14-1dd2-11b2-0a00-880000000000
endstream
endobj
11 0 obj
<>
endobj
12 0 obj
<>
endobj
26 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
90 0 obj
[94 0 R]
endobj
91 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 57 714.5293 Tm
[(16.)-875.1 (Lassere MN, Bird P)110.7 (. Measurement of rheumatoid arthritis disease)]TJ
2.175 -1.25 Td
[(activity and damage using magnetic resonance imaging. )17.7 (T)35 (ruth and)]TJ
0 -1.25 TD
(discrimination: does MRI make the grade? J Rheumatol)Tj
0 Tc 0 Tw T*
[(2001;28:1)36.9 (151-7.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(17.)-875.1 (Conaghan P)110.7 (, Edmonds J, Emery P)110.8 (, et al. Magnetic resonance)]TJ
2.175 -1.25 Td
[(imaging in rheumatoid arthritis: summary of OMERACT)-257.3 (activities,)]TJ
T*
[(current status, and plans. J Rheumatol 2001;28:1)36.8 (158-61.)]TJ
-2.175 -1.25 Td
[(18.)-875.1 (Garnero P)110.7 (, Landewe R, Boers M, et al. )54.8 (Association of baseline)]TJ
2.175 -1.25 Td
(levels of markers of bone and cartilage degradation with long-term)Tj
T*
(progression of joint damage in patients with early rheumatoid)Tj
T*
[(arthritis: the COBRA)-220.2 (study)64.8 (. )54.8 (Arthritis Rheum 2002;46:2847-56.)]TJ
30.825 12.5 Td
[(19.)-875.1 (Molenaar ET)73.9 (, Lems )17.7 (WF)79.7 (, Dijkmans BA, de Koning MH, van de)]TJ
2.175 -1.25 Td
[(Stadt RJ, )17.7 (V)128.9 (oskuyl )54.8 (AE. Levels of markers of bone resorption are)]TJ
T*
(moderately increased in patients with inactive rheumatoid arthritis.)Tj
T*
(Rheumatology 2000;39:742-4.)Tj
-2.175 -1.25 Td
[(20.)-875.1 (Molenaar ET)73.9 (, )17.7 (V)128.9 (oskuyl )54.8 (AE, Dinant HJ, Bezemer PB, Dijkmans BA.)]TJ
2.175 -1.25 Td
(Progression of radiological damage in patients with rheumatoid)Tj
T*
[(arthritis in clinical remission [abstract]. )54.8 (Arthritis Rheum 2001;44)]TJ
0 Tc T*
(Suppl 9:S174.)Tj
ET
0 0 0 0 scn
425 770 133 -25 re
f*
BT
0 0 0 1 scn
/T1_1 1 Tf
0 Tw 20.37 0 0 21 463.082 753.6089 Tm
[(\002\003\003\004\005\006)54.9 (\006\003\005\004)]TJ
ET
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
/T1_2 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 54.5 35.9844 Tm
[(V)110.9 (oskuyl and Boers: Editorial)]TJ
0 Tc 0 Tw 61.4375 -0.0313 Td
(907)Tj
ET
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_3 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_4 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
30 0 obj
<>
endobj
35 0 obj
<>
endobj
32 0 obj
<>
endobj
73 0 obj
<>
endobj
85 0 obj
<>
endobj
31 0 obj
<>
endobj
56 0 obj
<>stream
HS{PSg7D(@ܵvP.m(,H]@vY!@$@x Wn yh}B8}92nϥݨgg?v̙oo~}?`8.+)$ /[X!.E֝˾e>k瞶cEf$EpoUY:`p.;Z:
9aZ;W{y{le䒤d%<zuxiDYS)bޖ gqJqMѯf\˳mWiD4NJtR!}U29-)DI\"V6Zp[`̑-`nl1-1O=[a[0̟gci[#l3`_nxrsp^pڅٍ~5҅lxɼ~:YnnΜ
F8?G38:[{9Q5/wiԏH-srU^$Mݭ4+ry